ENVALITH
理研ビタミン株式会社 logo

Riken Vitamin Co., Ltd.

4526・Prime Market・Foods

理研ビタミン株式会社 logo
Riken Vitamin Co., Ltd.4526

Governance

The company has adopted the structure of a company with an audit and supervisory committee, with a board of 12 directors (including 5 outside directors). It has established voluntary nomination and compensation committees, with independent outside directors serving as chair and holding a majority on each committee.

Nomination Committee

Established

Compensation Committee

Established

Risk Management

The company has established a Risk Management Committee to assess and manage risks related to market conditions, safety, raw material procurement, foreign exchange fluctuations, intellectual property rights, information management systems, natural disasters, legal regulations, and overseas business. Sustainability-related risks are also integrated into the company-wide risk management framework centered on this committee.

Shareholder Returns

Annual dividend for FY2026 (ending March 2026) is ¥110 per share (interim ¥55 + year-end ¥55), with a consolidated payout ratio of 46.2%. The same ¥110 dividend is forecast for FY2027 (ending March 2027) (expected payout ratio of 42.8%). As a subsequent event, the company resolved to conduct a share buyback of up to 900,000 shares and ¥2.0 billion between June and September 2026.

Dividend Policy

The company aims for a consolidated payout ratio of 40% or more and continues to pay stable dividends twice a year, at the interim and year-end. For FY2026 (ending March 2026), the annual dividend per share is ¥110 (increased from ¥94 in the previous period), and the same ¥110 dividend is forecast for FY2027 (ending March 2027).

Dividend

Paying

Share Buyback

Possible

Shareholder Benefits

None

ESG

The company has established a Sustainability Committee chaired by the Representative Director and President, advancing initiatives through subcommittees covering climate change, GHG reduction, diversity, and human rights. It has set a target to reduce GHG emissions (Scope 1 and 2) by 40% by FY2030 (ending March 2030) compared to FY2018 (ending March 2018) levels, and to achieve carbon neutrality by FY2050 (ending March 2050), while also conducting scenario analysis based on TCFD. The company discloses a ratio of women in managerial positions of 7.1% and a male childcare leave uptake rate of 95.2%.

Board Members

山木 一彦

取締役 会長

望月 敦

代表取締役 社長

仲野 隆久

代表取締役 専務 管理部門(コンプライアンス・総務・人事) 化成品事業部門担当

道津 信夫

代表取締役 専務 事業戦略部門 調達部門 ヘルスケア事業部門担当

冨取 隆浩

常務取締役 管理部門(サステナビリティ・経理・システム) 経営戦略部門担当

中野 正明

取締役 食品改良剤事業部門 国際事業部門担当

平野 伸一

取締役

牧之段 武彦

取締役 常勤監査等委員

藤永 敏

取締役 常勤監査等委員

末吉 永久

取締役 監査等委員

末吉 亙

取締役 監査等委員

氏原 亜由美

取締役 監査等委員

Last updated: July 19, 2026